CollPlant Biotechnologies Files May 2025 6-K Report
Ticker: CLGN · Form: 6-K · Filed: May 30, 2025 · CIK: 1631487
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
CollPlant filed its May 6-K, check the press release for updates.
AI Summary
CollPlant Biotechnologies Ltd. filed a Form 6-K on May 30, 2025, reporting on its activities for the month of May 2025. The filing includes a press release, which is incorporated by reference into the report. The company is a foreign private issuer and files under the 1934 Act.
Why It Matters
This filing provides an update on CollPlant's ongoing operations and regulatory compliance as a foreign private issuer. Investors can review the incorporated press release for specific business developments.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial information or significant strategic changes.
Key Players & Entities
- CollPlant Biotechnologies Ltd. (company) — Registrant
- 001-38370 (company) — Commission File Number
- May 2025 (date) — Reporting Period
- 20250530 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC to provide current information about the company, often including press releases or other material information not otherwise available.
What is CollPlant Biotechnologies Ltd.'s primary business?
CollPlant Biotechnologies Ltd. is primarily involved in the orthopedic, prosthetic & surgical appliances & supplies industry, as indicated by its SIC code 3842.
When was this Form 6-K filed?
This Form 6-K was filed on May 30, 2025.
Does CollPlant Biotechnologies Ltd. file annual reports under Form 20-F or 40-F?
CollPlant Biotechnologies Ltd. indicates that it files annual reports under Form 20-F.
What is the company's principal executive office address?
The company's principal executive office is located at 4 Oppenheimer St, Weizmann Science Park, Rehovot 7670104, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 30, 2025 regarding CollPlant Biotechnologies Ltd (CLGN).